Document is current
Any future updates will be listed below
-
Authors
Hustings, Nico https://orcid.org/0000-0002-1805-6315
Thonissen, Yannick https://orcid.org/0000-0002-9267-7208
Cockmartin, Lesley https://orcid.org/0000-0003-2449-5872
Vanderseypen, Koen
Baldewijns, Marcella https://orcid.org/0000-0002-0882-2944
De Catte, Luc https://orcid.org/0000-0002-5287-9673
Thal, Dietmar Rudolf https://orcid.org/0000-0002-1036-1075
Aertsen, Michael https://orcid.org/0000-0003-1994-5365
- License Information
-
More Information
Article History
Received: 1 September 2022
Revised: 20 September 2022
Accepted: 1 December 2022
First Online: 29 December 2022
Declarations
:
: Author D.R.T. received speaker honorarium from Novartis Pharma Basel (Switzerland) and Biogen (USA), travel reimbursement from GE Healthcare (UK), and UCB (Belgium), and collaborated with GE Healthcare (UK), Novartis Pharma Basel (Switzerland), Probiodrug (Germany), and Janssen Pharmaceutical Companies (Belgium). Author D.R.T. also receives funding from FWO (G0F8516N, G065721N) and SAO/FRA (2020/017). The other authors declare no conflicts of interest.
